This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Transvaginal Mesh Lawsuit Update: Expert Tells Jury Prolift Mesh Makers Ignored His Warnings About Mesh's Dangers, Rottenstein Law Group Reports

ATLANTIC CITY, N.J., Feb. 7, 2013 /PRNewswire/ -- The makers of a transvaginal mesh product that has sparked thousands of personal injury lawsuits ignored the advice of an expert who warned them that the product was dangerous, according to that expert's testimony in New Jersey Superior Court earlier this week.

(Logo: ) On Feb. 4, 2013, Dr. Uwe Klinge, a world-renowned expert on the biocompatibility of surgical mesh, told a jury about a talk he delivered in 2005 to Johnson & Johnson's Ethicon unit. During that talk, Dr. Klinge explained that, in order to be safe for patients, surgical mesh used in the pelvis would need to be very lightweight and have pores that are at least 1 millimeter in all directions. Later that year, Ethicon nevertheless began to market the Prolift vaginal mesh kit, a product with mesh that was larger and heavier than Dr. Klinge said it needed to be to be safe for patients.

Dr. Klinge testified that he was not specifically involved with the development of the Prolift, but said that Ethicon executives were well aware of his surgical-mesh-safety research findings, and knew that the Prolift vaginal mesh product would lead to safety issues for patients.

The trial at which Dr. Klinge delivered his testimony is the first of 1,800 transvaginal mesh lawsuits against Ethicon pending in New Jersey Superior Court to go to trial.

As a representative of women who claim they've been harmed by vaginal mesh products, Rochelle Rottenstein, the Rottenstein Law Group's principal, implores women who believe they've been hurt by these implants to call the Rottenstein Law Group's offices for a free evaluation of their ability to file a lawsuit right away.

"We're relieved that one of the Prolift cases has gone to trial, and look forward to helping many of the other women who've been seriously harmed by vaginal mesh products recover compensation for their injuries," Rottenstein says.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free


Chart of I:DJI
DOW 16,472.37 +200.36 1.23%
S&P 500 1,951.36 +27.54 1.43%
NASDAQ 4,707.7750 +80.6910 1.74%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs